Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors

Molecular Biology of the Cell

Volumn 24, Issue 23, 2013, Pages 3634-3650

  Grant, Gavin D ^a   Brooks III, Lionel ^a   Zhang, Xiaoyang ^a   Mahoneya, J Matthew ^a   Martyanov, Viktor ^a   Wood, Tammara A ^a   Sherlock, Gavin ^b   Cheng, Chao ^a   Whitfield, Michael L ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F6; TRANSCRIPTION FACTOR FOXM1; TRANSCRIPTION FACTOR GABPA; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL LINE; CELL SYNCHRONIZATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; HELA CELL; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; MITOSIS; NUCLEOSOME; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL;

CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; E2F TRANSCRIPTION FACTORS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; HELA CELLS; HUMANS; MULTIGENE FAMILY; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 84888999409     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-05-0264     Document Type: Article

References (91)

1. Ahmad A, Ali S, Wang Z, Ali AS, Sethi S, Sakr WA, Raz A, Rahman KM (2011). 3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1. Int J Cancer 129, 1781-1791.
2. Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH (2010). FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat 122, 337-346.
3. Ahmed M et al. (2012). FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma. J Clin Endocrinol Metab 97, E1-E13.
4. Alter O, Brown PO, Botstein D (2000). Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA 97, 10101-10106.
5. Alvarez-Fernandez M, Halim VA, Krenning L, Aprelia M, Mohammed S, Heck AJ, Medema RH (2010). Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1. EMBO Rep 11, 452-458.
6. Alvarez-Fernandez M, Medema RH (2013). Novel functions of FoxM1: from molecular mechanisms to cancer therapy. Front Oncol 3, 30.
7. Bar-Joseph Z, Siegfried Z, Brandeis M, Brors B, Lu Y, Eils R, Dynlacht BD, Simon I (2008). Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells. Proc Natl Acad Sci USA 105, 955-960.
8. Bergamaschi A, Christensen BL, Katzenellenbogen BS (2011). Reversal of endocrine resistance in breast cancer: Interrelationships among 14-3-3zeta, FOXM1, and a gene signature associated with mitosis. Breast Cancer Res 13, R70.
9. Bonet C, Giuliano S, Ohanna M, Bille K, Allegra M, Lacour JP, Bahadoran P, Rocchi S, Ballotti R, Bertolotto C (2012). Aurora B Is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells. J Biol Chem 287, 29887-29898.
10. Calvisi DF et al. (2009). Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut 58, 679-687.
11. Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC, Fang FM, Huang HY, Chen CM, Liu HL, Huang CY (2009). Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene 28, 2723-2737.
12. Chen YJ, Dominguez-Brauer C, Wang Z, Asara JM, Costa RH, Tyner AL, Lau LF, Raychaudhuri P (2009). A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1. J Biol Chem 284, 30695-30707.
13. Chen X, Muller GA, Quaas M, Fischer M, Han N, Stutchbury B, Sharrocks AD, Engeland K (2013). The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism. Mol Cell Biol 33, 227-236.
14. Chen W, Yuan K, Tao ZZ, Xiao BK (2011). Deletion of forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells. Asian Pac J Cancer Prev 12, 1785-1788.
15. Chetty C, Bhoopathi P, Rao JS, Lakka SS (2009). Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 124, 2468-2477.
16. Cho RJ et al. (1998). A genome-wide transcriptional analysis of the mitotic cell cycle. Mol Cell 2, 65-73.
17. Cho RJ, Huang M, Campbell MJ, Dong H, Steinmetz L, Sapinoso L, Hampton G, Elledge SJ, Davis RW, Lockhart DJ (2001). Transcriptional regulation and function during the human cell cycle. Nat Genet 27, 48-54.
18. Crawford DF, Piwnica-Worms H (2001). The G(2) DNA damage checkpoint delays expression of genes encoding mitotic regulators. J Biol Chem 276, 37166-37177.
19. Dai B, Kang SH, Gong W, Liu M, Aldape KD, Sawaya R, Huang S (2007). Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 26, 6212-6219.
20. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3.
21. Doong H, Price J, Kim YS, Gasbarre C, Probst J, Liotta LA, Blanchette J, Rizzo K, Kohn E (2000). CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene 19, 4385-4395.
22. Down CF, Millour J, Lam EW, Watson RJ (2012). Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb. Biochim Biophys Acta 1819, 855-862.
23. Eisen MB, Spellman PT, Brown PO, Botstein D (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95, 14863-14868.
24. Fenton TR, Gout IT (2011). Functions and regulation of the 70 kDa ribosomal S6 kinases. Int J Biochem Cell Biol 43, 47-59.
25. Gao D, Inuzuka H, Korenjak M, Tseng A, Wu T, Wan L, Kirschner M, Dyson N, Wei W (2009). Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways. Mol Biol Cell 20, 3305-3316.
26. Gemenetzidis E et al. (2009). FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One 4, e4849.
27. Gerstein MB et al. (2012). Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91-100.
28. Grant GD, Gamsby J, Martyanov V, Brooks L 3rd, George LK, Mahoney JM, Loros JJ, Dunlap JC, Whitfield ML (2012). Live-cell monitoring of periodic gene expression in synchronous human cells identifies forkhead genes involved in cell cycle control. Mol Biol Cell 23, 3079-3093.
29. Helin K (1998). Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8, 28-35.
30. Huang C, Qiu Z, Wang L, Peng Z, Jia Z, Logsdon CD, Le X, Wei D, Huang S, Xie K (2012). A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res 72, 655-665.
31. Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57.
32. Hui MK, Chan KW, Luk JM, Lee NP, Chung Y, Cheung LC, Srivastava G, Tsao SW, Tang JC, Law S (2012). Cytoplasmic forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World J Surg 36, 90-97.
33. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, Nevins JR (2001). Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 21, 4684-4699.
34. Iyer VR et al. (1999). The transcriptional program in the response of human fibroblasts to serum. Science 283, 83-87.
35. Johnson DG, Ohtani K, Nevins JR (1994). Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8, 1514-1525.
36. Kalinichenko VV, Gusarova GA, Tan Y, Wang IC, Major ML, Wang X, Yoder HM, Costa RH (2003). Ubiquitous expression of the forkhead box M1B transgene accelerates proliferation of distinct pulmonary cell types following lung injury. J Biol Chem 278, 37888-37894.
37. Kim IM, Ramakrishna S, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV (2005). The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature. J Biol Chem 280, 22278-22286.
38. Kittler R et al. (2007). Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat Cell Biol 9, 1401-1412.
39. Kwok JM, Peck B, Monteiro LJ, Schwenen HD, Millour J, Coombes RC, Myatt SS, Lam EW (2010). FOXM1 confers acquired cisplatin resistance in breast cancer cells. Mol Cancer Res 8, 24-34.
40. Laoukili J, Alvarez M, Meijer LA, Stahl M, Mohammed S, Kleij L, Heck AJ, Medema RH (2008a). Activation of FoxM1 during G2 requires cyclin A/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain. Mol Cell Biol 28, 3076-3087.
41. Laoukili J, Alvarez-Fernandez M, Stahl M, Medema RH (2008b). FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner. Cell Cycle 7, 2720-2726.
42. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH (2005). FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7, 126-136.
43. Laub MT, McAdams HH, Feldblyum T, Fraser CM, Shapiro L (2000). Global analysis of the genetic network controlling a bacterial cell cycle. Science 290, 2144-2148.
44. Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, Velmurugan S, Chen R, Washburn MP, Liu XS, DeCaprio JA (2007). Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 26, 539-551.
45. Liu M et al. (2006). FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 66, 3593-3602.
46. Liu T et al. (2011). Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol 12, R83.
47. Liu S et al. (2012). MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 56, 389-396.
48. Lok GT, Chan DW, Liu VW, Hui WW, Leung TH, Yao KM, Ngan HY (2011). Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells. PLoS One 6, e23790.
49. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M (2008). FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958-970.
50. Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ (2012). Critical role of O-Linked beta-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem 287, 11070-11081.
51. Madureira PA, Varshochi R, Constantinidou D, Francis RE, Coombes RC, Yao KM, Lam EW (2006). The forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem 281, 25167-25176.
52. Major ML, Lepe R, Costa RH (2004). Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol Cell Biol 24, 2649-2661.
53. Menges M, de Jager SM, Gruissem W, Murray JA (2005). Global analysis of the core cell cycle regulators of Arabidopsis identifies novel genes, reveals multiple and highly specific profiles of expression and provides a coherent model for plant cell cycle control. Plant J 41, 546-566.
54. Menges M, Hennig L, Gruissem W, Murray JA (2002). Cell cycle-regulated gene expression in Arabidopsis. J Biol Chem 277, 41987-42002.
55. Mukherji M et al. (2006). Genome-wide functional analysis of human cell-cycle regulators. Proc Natl Acad Sci USA 103, 14819-14824.
56. Nakamura S, Hirano I, Okinaka K, Takemura T, Yokota D, Ono T, Shigeno K, Shibata K, Fujisawa S, Ohnishi K (2010). The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Carcinogenesis 31, 2012-2021.
57. Oliva A, Rosebrock A, Ferrezuelo F, Pyne S, Chen H, Skiena S, Futcher B, Leatherwood J (2005). The cell cycle-regulated genes of Schizosaccharomyces pombe. PLoS Biol 3, e225.
58. Park YY et al. (2012). FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis 33, 1843-1853.
59. Park HJ, Costa RH, Lau LF, Tyner AL, Raychaudhuri P (2008). Anaphase-promoting complex/cyclosome-CDH1-mediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase. Mol Cell Biol 28, 5162-5171.
60. Pena-Diaz J, Hegre SA, Anderssen E, Aas PA, Mjelle R, Gilfillan GD, Lyle R, Drablos F, Krokan HE, Saetrom P (2013). Transcription profiling during the cell cycle shows that a subset of Polycomb-targeted genes is upregulated during DNA replication. Nucleic Acids Res 41, 2846-2856.
61. Peng X et al. (2005). Identification of cell cycle-regulated genes in fission yeast. Mol Biol Cell 16, 1026-1042.
62. Ponten J, Saksela E (1967). Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 2, 434-447.
63. Romano MF et al. (2003a). BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ 10, 383-385.
64. Romano MF et al. (2003b). BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol Ther 2, 508-510.
65. Rozen S, Skaletsky H (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132, 365-386.
66. Rustici G, Mata J, Kivinen K, Lio P, Penkett CJ, Burns G, Hayles J, Brazma A, Nurse P, Bahler J (2004). Periodic gene expression program of the fission yeast cell cycle. Nat Genet 36, 809-817.
67. Sadasivam S, Duan S, DeCaprio JA (2012). The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev 26, 474-489.
68. Shin H, Liu T, Manrai AK, Liu XS (2009). CEAS: cis-Regulatory Element Annotation System. Bioinformatics 25, 2605-2606.
69. Sinclair CS, Rowley M, Naderi A, Couch FJ (2003). The 17q23 amplicon and breast cancer. Breast Cancer Res Treat 78, 313-322.
70. Slansky JE, Farnham PJ (1996). Introduction to the E2F family: protein structure and gene regulation. Curr Top Microbiol Immunol 208, 1-30.
71. Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, Eisen MB, Brown PO, Botstein D, Futcher B (1998). Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell 9, 3273-3297.
72. Takayama S, Xie Z, Reed JC (1999). An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 274, 781-786.
73. Teh MT et al. (2013). Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis. Int J Cancer 132, 2095-210.
74. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB (2001). Missing value estimation methods for DNA microarrays. Bioinformatics 17, 520-525.
75. Wan X, Yeung C, Kim SY, Dolan JG, Ngo VN, Burkett S, Khan J, Staudt LM, Helman LJ (2012). Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma. Cancer Res 72, 5889-5899.
76. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH (2007). Down-regulation of forkhead box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67, 8293-8300.
77. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV, Costa RH, Raychaudhuri P, Tyner AL, Lau LF (2008). FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 283, 20770-20778.
78. Wang M, Gartel AL (2011). The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA. Oncotarget 2, 1218-1226.
79. Wang ZF, Whitfield ML, Ingledue TC 3rd, Dominski Z, Marzluff WF (1996). The protein that binds the 3' end of histone mRNA: a novel RNA-binding protein required for histone pre-mRNA processing. Genes Dev 10, 3028-3040.
80. Waseem A, Ali M, Odell EW, Fortune F, Teh MT (2010). Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Oral Oncol 46, 536-542.
81. Whitfield ML et al. (2002). Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 13, 1977-2000.
82. Whitfield ML, Zheng LX, Baldwin A, Ohta T, Hurt MM, Marzluff WF (2000). Stem-loop binding protein, the protein that binds the 3' end of histone mRNA, is cell cycle regulated by both translational and posttranslational mechanisms. Mol Cell Biol 20, 4188-4198.
83. Wierstra I, Alves J (2006a). FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha. Biochem Biophys Res Commun 348, 99-108.
84. Wierstra I, Alves J (2006b). Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4. Biol Chem 387, 949-962.
85. Wierstra I, Alves J (2007). FOXM1, a typical proliferation-associated transcription factor. Biol Chem 388, 1257-1274.
86. Wierstra I, Alves J (2008). Cyclin E/Cdk2, P/CAF, and E1A regulate the transactivation of the c-myc promoter by FOXM1. Biochem Biophys Res Commun 368, 107-115.
87. Wonsey DR, Follettie MT (2005). Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 65, 5181-5189.
88. Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K (2012). Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. J Hepatol 57, 600-612.
89. Xue YJ et al. (2012). Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. J Transl Med 10, 200.
90. Yamnik RL, Digilova A, Davis DC, Brodt ZN, Murphy CJ, Holz MK (2009). S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation. J Biol Chem 284, 6361-6369.
91. Zhang Y et al. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biol 9, R137.